SARS-CoV-2 Kit


Oxford Immunotec

The T-SPOT® Discovery SARS-CoV-2 kit has been developed to aid in the investigation of the T cell response to SARS-CoV-2 infection. The kit uses a modified ELISPOT assay where samples prepared from peripheral blood are stimulated in vitro by peptide pools from SARS-CoV-2. This re-stimulation allows SARS-CoV-2 specific T cells to be enumerated. The kit builds on Oxford Immunotec’s experience with tuberculosis diagnosis and the assessment of immune response to cytomegalovirus in transplant patients, to apply the company’s established, proprietary T-SPOT technology to the fight against COVID-19.

This site uses Akismet to reduce spam. Learn how your comment data is processed.